Logotype for Chatham Lodging Trust

Chatham Lodging Trust (CLDT) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Chatham Lodging Trust

Q2 2025 earnings summary

23 Nov, 2025

Executive summary

  • Completed sale of five hotels for $83 million at a 6% cap rate on 2024 NOI, targeting lower-performing assets and further de-leveraging the balance sheet.

  • Portfolio consisted of 34 hotels with 5,166 rooms across 15 states and D.C. as of June 30, 2025.

  • Initiated a $25 million share repurchase program, buying back 20,480 shares at a $7.02 average price in Q2.

  • Operationally, Q2 RevPAR and FFO per share were at the top of guidance, with occupancy at 82%, matching post-pandemic highs.

  • Net income to common shareholders was $3.4 million, down from $4.9 million year-over-year; diluted EPS was $0.07 vs. $0.10.

Financial highlights

  • Q2 2025 hotel EBITDA: $30.9 million; adjusted EBITDA: $28.5 million, both down year-over-year due to asset sales.

  • Adjusted FFO for Q2 2025 was $18.5 million ($0.36 per share), compared to $19.9 million ($0.39 per share) last year.

  • Total revenue for Q2 2025 was $80.3 million, down 7.2% year-over-year.

  • GOP margin for Q2: 46.3%, up 30 bps year-over-year; Hotel EBITDA margin declined 40 bps to 39%.

  • Declared $0.09 per share common dividend and $0.41406 per preferred share.

Outlook and guidance

  • Q3 2025 guidance: RevPAR $153–$156, growth of -1.5% to +0.5%, adjusted EBITDA $24.7–$26.8 million, adjusted FFO $0.29–$0.33 per share.

  • Full-year 2025 guidance: RevPAR flat to +1%, adjusted EBITDA $89–$93 million, adjusted FFO per share $0.95–$1.03.

  • Guidance assumes no further asset sales, capital markets activity, or floating rate changes.

  • Company expects to invest $9.3 million in renovations and improvements for the remainder of 2025.

  • Industry RevPAR decreased 0.5% for Q2 2025, with limited visibility for the remainder of 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more